KCNQ1
KCNQ1 is a gene that encodes a protein known as the potassium voltage-gated channel subfamily Q member 1. This protein is integral to the proper function of cardiac and epithelial cells. The KCNQ1 gene is located on chromosome 11 in humans and plays a critical role in the electrical activity of the heart and in the transport of ions across epithelial cells.
Function[edit | edit source]
The KCNQ1 protein forms a voltage-gated potassium channel that is essential for repolarizing the cardiac action potential and thus helps in maintaining the normal rhythm of the heart. In epithelial cells, KCNQ1 channels are involved in the transport of potassium ions, which is crucial for processes such as salt and water balance in the body.
Clinical Significance[edit | edit source]
Mutations in the KCNQ1 gene are associated with several medical conditions. One of the most notable is Long QT Syndrome (LQTS), specifically types 1 and 2, which are forms of a heart condition that can cause irregular heartbeats. These irregularities can lead to fainting, seizures, or sudden death. Early diagnosis and management are crucial for individuals with LQTS.
KCNQ1 mutations are also linked to an increased risk of Atrial Fibrillation, a common type of irregular heartbeat. Furthermore, these mutations can cause congenital deafness when they disrupt the function of potassium channels in the inner ear.
Genetic Aspects[edit | edit source]
The KCNQ1 gene exhibits allelic heterogeneity, meaning that different mutations in the same gene can cause different disorders. It is inherited in an autosomal dominant manner in cases of Long QT Syndrome, meaning that only one copy of the mutated gene is sufficient to cause the disorder.
Research[edit | edit source]
Ongoing research on KCNQ1 includes studies aimed at understanding the detailed mechanisms by which mutations lead to specific diseases and the development of targeted therapies that can modulate the function of the KCNQ1 channel. This research is crucial for developing new treatments for conditions associated with KCNQ1 mutations.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD